Literature DB >> 12636960

Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial.

Markus J Steiner1, Rosalie Dominik, R Wesley Rountree, Kavita Nanda, Laneta J Dorflinger.   

Abstract

OBJECTIVE: To compare the contraceptive effectivenesses of a polyurethane condom and a standard latex condom. Secondary outcomes of interest were safety, functionality, discontinuation, and acceptability.
METHODS: We randomized 901 couples to use either the polyurethane condom or a standard latex condom as their only form of contraception. We tested for pregnancy at enrollment and at every scheduled follow-up visit (weeks 4, 10, 16, 22, and 30).
RESULTS: The 6-month typical-use pregnancy probabilities were 9.0% (95% confidence interval [CI] 5.9, 12.2) for the polyurethane group and 5.4% (95% CI 2.9, 7.8) for the latex group; the hazard ratio was 1.7 (95% CI 1.1, 2.7), and we failed to reject the null hypothesis of our test of noninferiority. Females in the polyurethane group reported fewer genital irritations (hazard ratio 0.6; 95% CI 0.5, 0.8; P <.01), whereas males in both groups reported the same number of genital irritations (hazard ratio 1.0; 95% CI 0.7, 1.5; P =.94). Total clinical failures (breakage and slippage) were 8.4% for the polyurethane condom and 3.2% for the latex condom (difference 5.3%, 90% CI 2.8, 7.7). The risk of discontinuation did not differ between groups. Participants judged both condoms favorably in terms of the four primary acceptability outcomes (willingness to purchase, willingness to recommend, confidence in method, and general comfort).
CONCLUSION: The polyurethane condom was not shown to be as effective as the latex comparator condom for pregnancy prevention. However, the risk of pregnancy in the polyurethane group falls in the range of other barrier methods. For people with latex sensitivity or who find latex condoms unacceptable, this polyurethane condom represents one of several synthetic male condom alternatives currently available on the US market.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12636960     DOI: 10.1016/s0029-7844(02)02732-1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

Review 1.  Contraceptive failure in the United States.

Authors:  James Trussell
Journal:  Contraception       Date:  2011-03-12       Impact factor: 3.375

Review 2.  Complementary and alternative medicines: the herbal male contraceptives.

Authors:  Fanuel Lampiao
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-07-03

Review 3.  Male contraception.

Authors:  John K Amory
Journal:  Fertil Steril       Date:  2016-09-24       Impact factor: 7.329

Review 4.  Understanding contraceptive failure.

Authors:  James Trussell
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2009-02-14       Impact factor: 5.237

Review 5.  Advances in male contraception.

Authors:  Stephanie T Page; John K Amory; William J Bremner
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

6.  Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness.

Authors:  Elizabeth G Raymond; Pai Lien Chen; Bosny Pierre-Louis; Joanne Luoto; Kurt T Barnhart; Lynn Bradley; Mitchell D Creinin; Alfred Poindexter; Livia Wan; Mark Martens; Robert Schenken; Cate F Nicholas; Richard Blackwell
Journal:  BMC Med Res Methodol       Date:  2004-10-01       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.